Cite

HARVARD Citation

    Qu, M. et al. (n.d.). 23: Cost-Effectiveness of Sabr in Oligometastatic Cancer: An Economic Analysis Based on Long-Term Results of the SABR-Comet Randomized Trial. Radiotherapy and oncology. pp. S13-. [Online]. 
  
Back to record